Alkali Metals Limited manufactures and sells chemicals in India and internationally. The company offers API products, including benzocaine, fluconazole, loperamide hydrochloride, losartan potassium, metformin hydrochlorβ¦
ISININE773I01017
Listedβ
Quarters tracked13
Filings20 docs
Market Price
OpenHighLowPrev Close
Price unavailable
About
Alkali Metals Limited manufactures and sells chemicals in India and internationally. The company offers API products, including benzocaine, fluconazole, loperamide hydrochloride, losartan potassium, metformin hydrochloride, phenylephrine hydrochloride, and rabeprazole sodium. It also provides pyridine, acetylpyridine, alkyl borate, aminopyridine, bipyridine, bromopyridine, carbazole, chloropyridine, cyanopyridine, cyclic, diethylamino pyridine, ethoxypyridine, fluoropyridine, hydroxypyridine, methoxypyridine, nitropyridine, picolylalcohol, pyridine n-oxide, pyrimidine, quinoline, tetrazole, and triazole compounds; azaindole, potassium, sodium, and other metal derivatives; boronic acids, and DSSC and OLED materials; and organic, inorganic, and fine chemicals. The company's products are used in pharma intermediates, anti retrovirals, flu vaccines, antibiotics, cardio/anti inflammation, agrochemicals, and automobiles applications. Alkali Metals Limited was incorporated in 1968 and is based in Hyderabad, India.
Key Metrics
as of Sep 2026
Market Cap67 Cr
P/E61.80
Div Yield1.53 %
Book ValueβΉ43.90
52w HighβΉ107.00
52w LowβΉ46.80
Face ValueβΉ10.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
17.57
28.73
24.91
18.77
20.61
24.87
22.34
20.46
14.67
24.42
24.55
16.84
17.05
Expenses
17.91
22.65
25.17
18.59
19.06
21.70
24.29
20.69
16.40
22.53
21.78
15.11
15.28
Operating Profit
-0.34
6.08
-0.26
0.18
1.55
3.17
-1.95
-0.23
-1.73
1.89
2.77
1.73
1.77
OPM %
-1.94
21.16
-1.04
0.96
7.52
12.75
-8.73
-1.12
-11.79
7.74
11.28
10.27
10.38
Other Income
0.77
0.28
0.24
0.05
0.04
0.28
-1.21
0.10
0.08
0.17
0.10
0.20
0.08
Depreciation
0.70
0.66
0.68
0.72
0.82
0.90
1.08
1.08
1.09
1.15
1.17
1.15
1.13
Interest
0.37
0.40
0.69
0.42
0.44
0.52
0.50
0.80
0.58
0.51
0.75
0.69
0.61
Profit before tax
-0.64
5.30
-1.39
-0.91
0.33
2.03
-4.74
-2.01
-3.32
0.40
0.95
0.09
0.11
Tax %
0.00
24.15
0.00
0.00
448.48
-114.29
4.22
-5.47
0.00
-42.50
62.11
0.00
0.00
Net Profit
-0.64
4.02
-1.39
-0.91
-1.15
4.35
-4.93
-1.90
-3.32
0.56
0.36
0.10
0.11
EPS in Rs
-0.63
3.95
-1.37
-0.89
-1.13
4.27
-4.84
-1.87
-3.26
0.55
0.35
0.10
0.11
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Sales
93.03
82.33
82.86
88.23
91.02
55.38
70.85
71.56
64.93
61.12
73.28
68.44
Expenses
85.31
82.96
74.57
78.55
79.64
49.32
64.17
64.14
58.13
54.28
63.35
59.01
Operating Profit
7.72
-0.63
8.29
9.68
11.38
6.06
6.68
7.42
6.80
6.84
9.93
9.43
OPM %
8.30
-0.77
10.00
10.97
12.50
10.94
9.43
10.37
10.47
11.19
13.55
13.78
Other Income
0.61
-0.75
0.42
1.05
0.14
0.05
0.35
0.40
0.50
0.12
0.25
-0.35
Interest
2.13
2.51
2.56
2.67
2.63
2.54
2.47
2.71
2.52
2.96
3.44
4.50
Depreciation
2.89
4.15
4.60
4.29
3.86
3.35
3.45
3.41
3.48
3.62
3.75
4.27
Profit before tax
3.31
-8.04
1.55
3.77
5.03
0.22
1.11
1.70
1.30
0.38
2.99
0.31
Tax %
83.38
-27.86
27.10
22.55
30.82
650.00
-12.61
0.00
0.00
7.89
24.41
6.45
Net Profit
0.56
-5.80
1.13
2.91
3.48
-1.21
1.25
1.69
1.31
0.35
2.26
0.28
EPS in Rs
0.55
-5.70
1.11
2.86
3.42
-1.19
1.23
1.66
1.29
0.34
2.22
0.27
Dividend Payout %
181.79
-8.78
90.09
69.97
58.51
-67.31
81.44
72.28
77.71
145.43
54.05
0.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Equity Capital
10.18
10.18
10.18
10.18
10.18
10.18
10.18
10.18
10.18
10.18
10.18
10.18
Reserves
34.51
34.34
41.16
42.68
41.90
39.19
40.10
41.85
41.20
40.34
39.97
39.19
Borrowings
18.13
18.18
22.84
23.82
17.25
21.92
19.99
18.19
18.08
21.44
21.69
32.75
Other Liabilities
30.05
28.38
31.33
25.24
27.42
24.96
16.98
20.81
19.46
17.55
15.14
12.47
Total Liabilities
92.87
91.08
105.51
101.92
96.75
96.25
87.25
91.03
88.92
89.51
86.98
94.59
Fixed Assets
38.46
41.03
47.29
49.47
46.27
46.66
44.87
44.76
46.82
49.84
53.71
57.00
CWIP
0.00
0.00
0.19
1.33
0.63
0.43
2.15
2.12
1.55
1.56
0.46
0.36
Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Assets
54.41
50.05
58.03
51.12
49.85
49.16
40.23
44.15
40.55
38.11
32.81
37.23
Total Assets
92.87
91.08
105.51
101.92
96.75
96.25
87.25
91.03
88.92
89.51
86.98
94.59
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Cash from Operating Activity
2.82
5.25
6.29
11.19
11.19
1.32
9.43
6.90
4.50
4.19
8.28
9.16
Cash from Investing Activity
-0.27
-0.75
-1.64
-3.14
-2.84
-3.52
-3.74
-2.81
-0.41
-0.97
-0.44
-2.11
Cash from Financing Activity
-2.54
-4.50
-5.71
-8.96
-6.82
0.07
-3.16
-4.08
-4.06
-3.26
-9.92
-5.53
Net Cash Flow
0.01
0.00
-1.06
-0.91
1.53
-2.13
2.53
0.02
0.03
-0.05
-2.08
1.52
Free Cash Flow
2.50
4.43
4.60
8.05
8.33
-2.24
5.63
3.99
4.01
3.05
7.72
6.83
CFO/OP %
37.00
-833.00
76.00
116.00
94.00
23.00
145.00
92.00
62.00
65.00
94.00
97.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Debtor Days
76.15
63.57
79.16
56.63
53.74
79.02
32.82
54.78
79.26
61.39
56.28
45.65
Inventory Days
223.59
223.28
381.69
277.93
245.90
493.80
233.58
241.56
194.18
251.90
119.11
176.18
Days Payable
203.67
161.04
281.00
180.30
165.04
318.70
121.63
169.77
166.75
182.90
116.85
111.92
Cash Conversion Cycle
96.08
125.82
179.84
154.26
134.59
254.13
144.76
126.57
106.70
130.39
58.55
109.91
Working Capital Days
20.48
0.18
31.50
20.52
25.91
48.57
5.31
14.69
7.65
-9.50
-24.01
-13.01
ROCE %
8.67
-4.70
5.99
8.94
11.11
4.10
5.41
6.31
5.47
5.05
8.35
6.97
Shareholding Pattern
% holding β latest first
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
69.59
69.59
69.59
69.59
69.59
69.59
69.59
69.59
69.59
69.59
69.59
69.59
FIIs
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.07
0.07
0.16
0.12
0.41
Public
30.40
30.41
30.42
30.41
30.41
30.41
30.42
30.35
30.34
30.26
30.30
30.00
No. of Shareholders
12,780
12,906
13,065
13,280
13,522
13,487
13,601
13,730
12,566
12,295
12,208
13,185
Corporate Actions
23 records
Action
Ex Date
Record Date
Ratio
Amount (βΉ)
Notes
Dividend
14 Aug 2026
14 Aug 2026
β
1.00
Dividend
14 Aug 2025
14 Aug 2025
β
0.50
Dividend
16 Aug 2024
β
β
1.00
Dividend
14 Aug 2023
β
β
2.00
Other
08 Dec 2022
β
β
β
E.G.M.
Other
08 Dec 2022
β
β
β
Extra Ordinary General Meeting
Dividend
11 Aug 2022
β
β
2.00
Dividend
12 Aug 2021
β
β
0.80
Other
17 Sep 2020
β
β
β
Annual General Meeting
Dividend
05 Feb 2020
06 Feb 2020
β
1.00
Dividend
25 Jul 2019
β
β
1.20
Dividend
21 Jun 2018
β
β
1.00
Dividend
27 Jul 2017
β
β
0.50
Dividend
21 Jul 2016
β
β
0.40
Dividend
04 Feb 2016
05 Feb 2016
β
0.80
Other
10 Sep 2015
β
β
β
Annual General Meeting
Other
13 Aug 2014
β
β
β
Annual General Meeting
Dividend
23 Jul 2013
β
β
1.00
Other
23 Jul 2013
β
β
β
Annual General Meeting / Final Dividend Re.1/- Per Equity Share